Background Venous thromboembolism (VTE) has been named a complication of sickle cell disease (SCD); nevertheless, the occurrence of VTE in SCD is normally unidentified. with 8,862 many years of follow-up within this evaluation. The occurrence price for initial VTE was 5.2 events/1000 person-years (95% self-confidence period (CI) 3.8, 6.9) using a cumulative incidence of 11.3%… Continue reading Background Venous thromboembolism (VTE) has been named a complication of sickle